Inhibition of NLRP3 Inflammasome Alleviates Postoperative Cognitive Impairment by Suppressing the HMGB-1/TLR4/NF-κB Pathway
- PMID: 40437299
- DOI: 10.1007/s11064-025-04416-9
Inhibition of NLRP3 Inflammasome Alleviates Postoperative Cognitive Impairment by Suppressing the HMGB-1/TLR4/NF-κB Pathway
Abstract
Perioperative neurocognitive disorders (PNDs), main complications of surgery and anesthesia in the elderly, are mainly associated with neuroinflammation and remain poorly understood. This study aimed to explore the function of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome in the development of PNDs. Male C57BL/6 mice underwent right carotid artery exposure surgery, with or without treatment with adeno-associated virus vectors carrying NLRP3 (AAV-NLRP3), which was administered either intracerebroventricularly or via tail vein injection. Mouse brain tissue was collected 24 h postoperatively for biochemical assays. Another group of mice was subjected to the Morris water maze and novel object recognition tests to assess their learning and memory abilities. The results revealed that surgery and anesthesia increased NLRP3 protein expression level and programmed cell death in the hippocampus of mice, leading to impaired learning and memory, while AAV-NLRP3 treatment attenuated these effects. Additionally, inhibition of high-mobility group protein box 1 (HMGB-1) expression level alleviated surgery-induced upregulation of Toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-κB), and NLRP3 in the hippocampus of mice. The NLRP3 inflammasome emerged critical for the occurrence of neuroinflammation and postoperative cognitive impairment, which could be alleviated by inhibiting NLRP3 inflammasome via the HMGB-1/TLR4/NF-κB pathway.
Keywords: HMGB-1; Inflammation; NLRP3 inflammasome; Perioperative neurocognitive disorders; Pro-inflammatory cytokines.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that there is no conflict of interest. Ethical Approval: The animal experiments were conducted in compliance with the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) and were approved by the Ethics Committee of General Hospital of Ningxia Medical University (Approval No. 2018-020). Consent to Participate: All experiments were carried out in accordance with relevant guidelines and regulations. Consent for Publication: Not applicable.
Similar articles
-
Rutaecarpine Attenuates Monosodium Urate Crystal-Induced Gouty Inflammation via Inhibition of TNFR-MAPK/NF-κB and NLRP3 Inflammasome Signaling Pathways.Chin J Integr Med. 2025 Jul;31(7):590-599. doi: 10.1007/s11655-025-4204-3. Epub 2025 May 8. Chin J Integr Med. 2025. PMID: 40338445
-
Inhibiting endoplasmic reticulum stress alleviates perioperative neurocognitive disorders by reducing neuroinflammation mediated by NLRP3 inflammasome activation.CNS Neurosci Ther. 2024 Oct;30(10):e70049. doi: 10.1111/cns.70049. CNS Neurosci Ther. 2024. PMID: 39432407 Free PMC article.
-
IFP35, a novel DAMP, aggravates neuroinflammation following acute ischemic stroke via TLR4/NF-κB/NLRP3 signaling.J Neuroinflammation. 2025 Jun 25;22(1):164. doi: 10.1186/s12974-025-03492-6. J Neuroinflammation. 2025. PMID: 40563086 Free PMC article.
-
Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy.Inflammopharmacology. 2025 May;33(5):2231-2262. doi: 10.1007/s10787-025-01729-7. Epub 2025 Apr 9. Inflammopharmacology. 2025. PMID: 40205269 Free PMC article. Review.
-
Decoding NLRP3 Inflammasome Activation in Alzheimer's Disease: A Focus on Receptor Dynamics.Mol Neurobiol. 2025 Aug;62(8):10792-10812. doi: 10.1007/s12035-025-04918-1. Epub 2025 Apr 15. Mol Neurobiol. 2025. PMID: 40232645 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources